Willlow bark extract: Multicomponent mixture for the treatment of inflammations and pain;Weidenrindenextrakt: Vielstoffgemisch gegen entzündungen und schmerzen

Pharmazeutische Zeitung

Volumn 152, Issue 8, 2007, Pages 16-22

  Keusgen, Michael ^a   Allgäuer Lechner, Cölestin ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Phyto Netzwerk München ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVONOID; PLANT EXTRACT; POLYPHENOL; SALICIN; UNCLASSIFIED DRUG; WILLOW EXTRACT;

ANALGESIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPYRETIC ACTIVITY; ARTICLE; BARK; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; PAIN;

EID: 33847783047     PISSN: 00317136     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Abdel-Aziz, H., et al., Polyphenols are of special relevance for the multiple mechanisms of action of the willow bark extract STW 33-I. Planta Medica 72, Nr. 11 (2006) P182.
2. Bhatt, A. D., Aspirin: aspiring for a century (1899 to 1999) and the willow bark is still batting! J. Assoc. Physicians India 46, Nr. 4 (1998) 374-376.
3. Bonatera, G., et al., Willow bark extract STW 33-I inhibits lipopolysaccharid-induced proinflammatory effects in human monocytes. Osteoarthritis Cartilage 11, Suppl. A, Abstr. P343 (2003) 122-123.
4. Chrubasik, S., Eisenberg, E., Treatment of rheumatic pain with herbal medicine in Europe. Pain Digest 8, Nr. 4 (1998) 231-236.
5. Chrubasik, S., et al., Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study. Am. J. Med. 109, Nr. 1 (2000) 9-14.
6. Chrubasik, S., et al., Treatment of low back pain with a herbal or synthetic anti-rheumatic: a randomized controlled study. Willow bark extract for low back pain. Rheumatology (Oxford) 40, Nr. 12 (2001) 1388-1393.
7. Eisenberg, E., et al., Dose-dependent allevation of low back pain with Assalix®, a special willow bark extract. Phytomedicine (Jena) 7, Suppl. 2. 3rd International Congress on Phytomedicine, Munich, October 2000.
8. ESCOP. Salicis cortex (Willow bark). Monographs on the medicinal use of plant drugs. European Scientific Cooperative on Phytomedicine. Sec. Ed. (2003) 445-451.
9. Fiebich, B. L., et al., Anti-inflammatory effects of Salix: Salix extracts as inhibitors of the expression and synthesis of cytokines, matrix-metalloproteases, prostaglandins and COX-2 in LPS-treated primary human monocytes and chrondrocytes. Osteoarthritis Cartilage 11, Suppl. A, Abstr. P332 (2003) 119.
10. Germann, I., Charakterisierung radikalfangender Eigenschaften pflanzlicher Entzündungshemmer. Dissertation. Tübingen Eberhard-Karls-Universität 2005.
11. Glinko, A., Pharmacological properties of a standardized extract from willow bark (Cortex Salicis). Pomeranian Acad. Med. 1998.
12. Jaeggi, R., et al., Osteoarthritis and inflammation: multiple target inhibition with the willow bark extract STW 33-I in vitro. Osteoarthritis Cartilage 11, Suppl. A, Abstr. P126 (2003) 46.
13. Kelber, O., et al., Effekte verschiedener Phytopharmaka auf den Zelltod von Human-Makrophagen. Perfusion 15, Nr. 2 (2002) 72-73.
14. Kelber, O., et al., Inhibitorische Effekte von Weidenrindenextrakten auf proinflammatorische Prozesse in LPS aktivierten Humanmonozyten. Z. Rheumatol., Suppl. 1 (2006) 31.
15. Khayyal, M. T., et al., Mechanisms involved in the anti-inflammatory effect of a standardized willow bark extract. Arzneimittelforschung 55, Nr. 11 (2005) 677-687.
16. Khayyal, M. T., et al., The anti-inflammatory, antipyretic and analgesic effect of willow bark extract, STW-33-I can not be explained solely on the basis of its salicin content. Osteoarthritis Cartilage 11, Suppl. A, Abstr. P192 (2003) 69.
17. Lardos, A., et al., Wirksamkeit und Verträglichkeit eines wässrig ausgezogenen Weidenrindenextraktes bei Patienten mit Hüftund Kniearthrose. Z. Phytother. 25 (2004) 275-281.
18. Leslie, G., A pharmacometric evaluation of nine Bio-Strath herbal remedies. Medica 10 (1878) 31-47.
19. Meier, B., Pharmaceutical aspects of the use of willows in herbal remedies. Planta Med. 54 (1988) 559-560.
20. Milde, J., et al., Salix extracts as inhibitors of the oxidative depolymerisation of hyaluronic acid. Osteoarthritis Cartilage 11, Suppl. A, P171 (2003) S62.
21. Monographie. Salicis cortex (Weidenrinde). Bundesanzeiger Nr. 228 vom 05. 12. 1984.
22. Müller, J., Kelber, O., Weiser, D., Weidenrindenpräparat (Rheumakaps®) bei rheumatischen Beschwerden, ein Erfahrungsbericht. Poster. Tagung Phytopharmaka und Phytotherapie, Berlin 2005.
23. Rohnert, U., et al., Inhibition by Salix-extracts and Phytodolor of copper-catalyzed oxidative destruction. Z. Naturforsch. [C] 53, Nr. 3-4 (1998) 233-240.
24. Schaffner, W., Weidenrinde - Ein Antirheumatikum der modernen Phytotherapie ? In: Chrubasik, S., Wink, M. (Hrsg.), Rheumatherapie mit Phytopharmaka. Hippokrates Stuttgart 1997, S. 125-127.
25. Schmid, B., et al., Effectiveness and tolerance of standardized willow bark extract in arthrosis patients. Randomized, placebo controlled double-blind study. Z. Rheumatol. 59, Nr. 5 (2000) 314-320.
26. Schmid, B., et al., Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized placebo-controlled, double blind clinical trial. Phytother. Res. 15, Nr. 4 (2001) 344-350.
27. Wagner, I., et al., Influence of willow bark extract on cyclooxygenase activity and on tumor necrosis factor alpha or interleukin 1 beta release in vitro and ex vivo. Clin. Pharmacol. Ther. 73, Nr. 3 (2003) 272-274.
28. Willuhn, G., Salicis cortex (Weidenrinde). In: Wichtl, M., Teedrogen und Phytopharmaka. Ein Handbuch für die Praxis auf wissenschaftlicher Grundlage. Wiss. Verlagsges. Stuttgart 1997, S. 517-520.
29. Wuthold, K., et al., Thin-layer chromatography and multivariate data analysis of willow bark extracts. J. Chromatogr. Sci. 42, Nr. 6 (2004) 306-309.